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1. Introduction
At least half the world's population are infected by Helicobacter pylori (H. pylori), making it the
most widespread infection in the world [1]. Although infection occurs worldwide, there are
significant differences in the prevalence of infection both within and between countries [2-4].
The overall prevalence of H. pylori infection in developed countries is lower than that in
developing countries [3, 5]. The increased infection rate in developing countries is likely due
to poor sanitary and/or living conditions. In such communities the incidence of H pylori
infection in infancy is also high [6, 7], and has also been associated with malnutrition and
growth faltering [8]. Epidemiological data suggest the prevalence of H. pylori infection in
children under 10 years resident in developed countries to be 0 to 5% compared to 13 to 60%
in their developing country counterparts [9]. The age at which this bacterium is acquired seems
to influence the possible pathologic outcome of the infection - people infected at an early age
are likely to develop more intense inflammation that may be followed by atrophic gastritis
with a higher risk of gastric ulcer, gastric cancer or both. Acquisition at an older age brings
different gastric changes that are more likely to result in duodenal ulcer. Individuals infected
with H. pylori have a 10 to 20% lifetime risk of developing peptic ulcers and a 1 to 2% risk of
acquiring stomach cancer [10]
H. pylori infection also exerts diverse effects of gastric physiology - it may increase or reduce
gastric acid secretion or result in no overall change in the acid output [11]. It is important to
know why H. pylori infection produces different aberrations in gastric physiology, and
consequently gastric or duodenal ulcer or gastric cancer. H. pylori infection has also been
suggested to be associated with a variety of conditions outside of the alimentary tract. The list
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of the proposed ‘extragastric’ association continues to grow despite the fact that H. pylori is a
non-invasive organism and as such the infections are essentially confined to the surface of
gastric-type mucosa. In an initial overview of the non-gastrointestinal manifestations of H.
pylori [12], some biological plausibility has been suggested that underlie its association with
iron deficiency anemia (IDA); cross sectional studies have demonstrated a relatively strong
association. [13]
In this chapter, we will review and update the consequence of H. pylori infection, its role on
the gastric acid secretion and some other conditions, notably IDA and iron absorption in
children. The relationship between H. pylori infection and vitamin C levels in the blood and
gastric juice will also be reviewed.
2. Consequences of initial H. pylori infection in children
There are not enough studies on the natural history of gastric infections in childhood years. In
older children and adolescents, and adults it appears that H. pylori infection and the accom‐
panying gastritis are lifelong unless specific eradication therapies are employed. However,
several epidemiological studies, using serology [14, [15] and breath tests ( [16, 17] as indirect
markers of gastric infection reported spontaneous clearance in the pre-school aged children.
Current evidence suggests that the overwhelming majority of H. pylori infected children and
adolescents develop a chronic-active, antral- predominant gastritis) [18]. There is a single
report suggesting the potential for H. pylori colonization of stomach of children without
mucosal inflammation in antrum or gastric fundus [19]. Although, infection with the Cag A-
positive strain was associated with more pronounced changes in the gastric physiology,
limited studies in children reported no association between Cag A status and the severity of
gastritis [20].
Some studies reported pan-gastritis involving both body and antrum in children infected with
H. plyori [21, 22]. However, a formal mapping study to delineate the extent and the severity of
bacterial colonization of the stomach, as well as the accompanying host cells mucosal inflam‐
matory response to infection is lacking. To date there are not enough studies in children
evaluating the healing of mucosal inflammation following eradication therapy. There are
indirect evidences to suggest that resolution of inflammatory response may occur more rapidly
in children than had been reported for adults [23]. In France, Ganga-Zandzou and colleagues
prospectively monitored the consequences of untreated H. pylori infection in a group of
asymptomatic children [24]. Although the density of bacterial colonization was not changed,
there was both marked antral nodularity and more severe mucosal inflammation in the antrum
over the 2-year follow-up of the children. However, there is the lack for comparable studies in
other pediatric population, e.g. among those residing in developing countries and a greater
length of follow-up. Further studies are needed to delineate the inflammatory and immune
responses during development in order to provide additional insights into the interactions
between the H. pylori and the host in such populations.
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2.1. H. pylori infection and gastric acid perturbation
Acid secretion by the gastric parietal cell is regulated by paracrine, endocrine, and neural
pathways. The physiological stimuli for acid secretion include histamine, acetylcholine, and
gastrin, each of which binds to receptors located on the basolateral plasma membranes of the
cells. The antral region of stomach contains G cells which release hormone gastrin. When meal
is ingested, the protein component stimulates G cell to release Gastrin, which travels through
the bloodstream to parietal cells in the body region (fundus) to secret acid [25]. Gastrin directly
does not stimulate parietal cells but stimulates the adjacent enterochromafin-like cell (ECL
cells) to release histamine, which in turn stimulates the parietal cells. Stimulation of acid
secretion typically involves an activation of a cAMP-dependent protein kinase cascade that
triggers the translocation and insertion of the proton pump enzyme, H,K-ATPase, into the
apical plasma membrane parietal cells [26]. As the acid accumulates and overcome the
buffering effects of the food, the fall in intragastric pH inhibits further release of gastrin and
thus prevents secretion of excessive amount of acids (negative feedback control).
Helicobacter pylori infection exerts diverse effects on gastric physiology. In acute H pylori
infection transient hypochlorhydria in adults is well documented [27, 28]. However, the
relationship between chronic H. pylori infection and gastric acid secretion is not fully under‐
stood. It may increase gastric acid secretion, reduce it or results no overall changes in acid
output. [11]. These alterations in acid secretion depend on the degree and distribution of
gastritis caused by the infection [29, 30]. In subjects with an antral predominant gastritis,
without atrophy, acid secretion is normal or increased. This is the pattern of gastritis seen in
patients who develops duodenal ulceration. When gastritis is body predominant, a situation
leading to gastric atrophy, H. pylori infection lead to markedly reduced acid secretion or
achlorhydria which is also seen in patients who develops non-cardiac gastric cancer. Finally,
when gastritis is mixed antral or body, H. pylori may have no effect on acid secretion.
2.2. H. pylori infection and increased acid output (hyperchlorhydria)
H. pylori infection in the antral region of the stomach disrupts the negative feedback control
of gastrin release, resulting inappropriately high and sustained levels of gastrin following meal
[31, 32]. In those subjects, the gastritis is non-atrophic and, therefore, the increased gastrin
release stimulates the healthy body region of stomach to secret excessive amounts of acid [33,
34]. The increased amount of acid output produced by this pattern of gastritis results in an
increased duodenal acid loads damaging the duodenal mucosa, which may eventually result
in ulcers formation [35]. Eradicating H. pylori infection in subjects with this type of gastritis
leads to lowering of serum gastrin with concomitant reductions in acid output.
2.3. H. pylori infection and low acid output (hypochlorhydria)
In subjects with atrophic gastritis or body predominant gastritis, there also is increased gastrin
release, but that is not accompanied with increased acid secretion. In such subjects, acid
secretion is reduced or completely absent (achlorhydria) [36, 37]. The low acid secretion,
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despite increased gastrin levels, indicates markedly impaired ability of oxyntic mucosa to
secret acid in response to gastrin. Following eradication of H. pylori infection in patients with
this pattern of gastritis, there is recovery in acid secretion [36, 37]. However, the degree of
recovery in acid outputs is variable – acid output resumes to normal level in some patients
while very small increase occur in others [36]. The recovery in acid outputs following eradi‐
cation of infection coincides with the disappearance of organism as well as resolution of
inflammation of the body mucosa. However, there is little evidence of resolution of the atrophy
of body mucosa. Capurso et al. (23) observed that both pangastritis and pangastritis-induced
hypochlorhydria were more prevalent in adult patients with H. pylori who had anemia than
in those who did not have anemia.
3. Role of H. pylori infection in gastric acid perturbation in children
There are only a few pediatric case reports on gastric acid secretion in H. pylori infection. Several
studies in the pre-H. pylori era [38, 39] and very recently [40] studies observed the maximal
acid output higher in children with duodenal ulcer than in the children without peptic-ulcer
disease. However, no study has examined the relationship between gastric acid secretion and
H. pylori infection in asymptomatic young children living in developing countries. The effect
of H. pylori on gastric acid production can be examined by studying individuals with and
without infection or, more directly by examining before and after eradication of H. pylori [41]
In an attempt to see if H. pylori infection is associated with gastric acid perturbation in
Bangladeshi children, basal gastric acid output (GAO-B) and stimulated gastric acid output
(GAO-S) just before and after pentagastrin stimulation in age matched H. pylori-infected and
non-infected children were measured. Experiments were repeated in infected children 8 weeks
after completing a 2-week course of anti-H. pylori therapy to evaluate the influence of H.
pylori on gastric acid secretion. Comparison of acid output between infected and non-infected
children both before and after eradication therapy is shown in Table 1. Both the basal acid
output (GAO-B) and the stimulated gastric acid outputs (GAO-S) were significantly lower in
H. pylori infected children compared to H. pylori negative group. The mean GAO-B and GAO-
S of the infected children were estimated to be 30% and 50% respectively of that of non-infected
children. Successful eradication therapy was associated with a significant rise of both the basal
and the stimulated acid output values reaching equivalence to those in the H. pylori-negative
children. Improvement of GAO following anti- H. pylori therapy suggests a causal link of H.
pylori infection and depressed GAO in this population. Whether the observed reversibility of
acid secretion to normal level within a relatively short term period of eradication therapy was
associated with recovery from corpus gastritis is not known as gastric biopsy for histological
examination was not performed. It is also important to know the acid secretory status after a
long term period of eradication in settings with possibilities of having re-infection by the
organism as a consequence of poor hygiene and environmental contamination.
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Non-infected
(n=30) p
Infected before
treatment (n=30) p
Infected after
treatment (n=28)
Basal Acid Output (BAO) 0.23 ± 0.30 0.06 0.62 ±0.9 NS 0.65 ± 0.65
Stimulated Acid Output 2.04 ±1.4 0.001 3.4 ±2.5 NS 3.3 ±2.1
Table 1. Comparison of acid outputs (mMol/h between infected and non-infected children along with effect of anti-
H. pylori therapy
4. Potential mechanisms of H. pylori-induced hypochlorhydria
H pylori induced hypochlorhydria might be due to the bacterium releasing some substances
that can directly inhibit acid secretion. Several candidate substances have been identified,
which inhibits parietal cell function in vitro, but the evidence for involvement of these sub‐
stances for the in-vivo effects remains weak. H. pylori infection also produces ammonia, which
may uncouple the proton pump [42]. But the ammonia produced by H. pylori infection in
hypochlorhdric subjects is relatively small [43]. Another problem in attributing the impairment
of oxyntic mucosal function to the presence of H. pylori organisms is that density of colonization
of the gastric mucosa with the organism is similar or lower in subjects with hypocholorhydria
than in subjects with normal or high acid secretion [36]. Therefore, current knowledge
precludes attributing impaired function of oxyntic mucosa as a direct effect of some bacterial
factor.
An alternative explanation for the impaired acid secretory function is infection-induced
inflammation of the oxyntic mucosa, since the severity of inflammation of the body mucosa is
more marked in subjects with H. pylori associated hypochlorhydria than in subjects with H.
pylori infection with normal or increased acid secretion [44]. This raises the possibility that a
product of inflammatory response following infection might inhibit acid secretion.
The molecular mechanisms underlying H. pylori-induced hypochlorhydria is not completely
understood. However, it has been shown that H. pylori–induced pro-inflammatory factors,
such as interleukin-1β, may contribute to hypochlorhydria [26, 45].The increased production
of this cytokines may be important because it is very potent inhibitor of acid secretion [46] and
and may play a role in chronic H. pylori-induced hypochlorhydria. Polymorphisms in IL-1β
gene cluster may control the extent and the duration of hypochlorhydria with initial H. pylori
infection [47], which has been noted to be linked to increased risk for atrophy and consequently
gastric cancer [48]. It is possible that inflammatory factors, such as IL-1β cause an inhibition
of acid secretion from parietal cells via paracrine pathways. Using freshly isolated rabbit gastric
glands and culture parietal cells, Fang and colleague observed that Vac-A toxin treatments
inhibits gastric acid secretion by preventing the recruitment of gastric H, K-adenosine
triphosphatase (H, K-ATPase), the parietal cell enzyme mediating acid secretion. [49]. This
was the first evidence that H. pylori Vac-A toxin impairs gastric parietal cell physiology by
disrupting the apical membrane cycloskeletal linkers of the gastric parietal cells. Studies in
animal models as well as epidemiologic studies of H. pylori isolates from humans have
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suggested that VacA toxin enhances the ability of H. pylori to colonize in the stomach and
contributes to the development of symptomatic diseases (15).
4.1. Potential consequences of H. pylori induced hypochlorhydria
H. pylori, by producing hypochlorhydria or impaired gastric barrier may contribute to
childhood malnutrition in developing countries through malabsorption or increased suscept‐
ibility to enteric infections [50]. Several observations demonstrated a correlation between H.
pylori and malabsorption of essential nutrients; epidemiological studies have shown an
association between H. pylori infection and iron deficiency anemia, while the absorption of
some vitamins such as vitamin B12, vitamin A, vitamin C, folic acid and Vitamin E may also
be affected by the infection [51]. The main mechanism related to malabsorption of these
components is the modified intragastric pH (hypo or achlorhydria) due to H. pylori infection.
On the other hand, H. pylori eradication has been shown to improve serum level of iron and
vitamin B12, and some effects on Vitamin A and Vitamin E absorption as well as late effects
on ghrelin levels [51].
5. H. pylori infection and iron deficiency anemia
5.1. Iron deficiency and iron deficiency anemia
Iron deficiency (ID) and iron deficiency anemia (IDA) are major public health problems,
especially in children and women of childbearing age in developing countries [52], and is
considered one of the ten leading global risks factors in terms of its attributable disease burden
[53]. It has been estimated that globally approximately 1.6 billion people, representing 25% of
the total population are anemic [54]. ID is considered to account for 50% of identified anemia,
and 800,000 deaths worldwide can be attributed to IDA. Deficiency of this trace element has
adverse implications on health at all stages of life. When iron deficiency occurs during critical
windows of brain development, the resultant cognitive deficits may be irreversible and
unresponsive to subsequent improvements in the iron status [55]. In adults, ID and IDA can
adversely impact physical work capacity and work productivity - variables that may have a
detrimental impact on their economic potential [56].
5.2. H. pylori and iron deficiency anemia
Several reports have demonstrated an association between H. pylori infection and anemia, ID,
and IDA, although the mechanisms of the interactions have not been well defined [13, 57-60].
A few case reports indicate that successful eradication of H. pylori results in improving iron
status and anemia [61-63]. Other studies implicate H. pylori as a cause of IDA, refractory to oral
iron treatment (refractory iron deficiency or sideropenic anemia); similarly eradication of H.
pylori has resulted in improved iron status in children [58, 64-67]. Overall, these findings
suggest that a substantial proportion of global ID and IDA might be attributed to H. pylori
infection, leading to a recommendation by some for H. pylori eradication therapy in infected
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individuals with unexplained IDA [68]. However, methodological limitations, including small
sample sizes and lacks of control groups, among others, do not allow conclusive interpretation
of the results. No previous study has examined whether or not active H. pylori infection is
causally linked to IDA in young children living in less developed countries. Although the
mechanisms for H. pylori-associated IDA is not fully understood, H. pylori-induced chronic pan
gastritis with resultant achlor-or hypo-chlorhydria [41, 69] and reduced ascorbic acid secretion
in the gastric mucosa [70, 71] may lead to reduced iron absorption since they are essential for
alimentary iron absorption; they not only convert ferric iron to the ferrous form, which
maintains solubility at the alkaline pH of the duodenum, but also chelates with ferric chloride
that is also stable at a pH >3. Uptake of iron by H. pylori is also suggested [72]. Whether H.
pylori is a cause or associated with ID or IDA is not fully elucidated.
In Bangladesh, a randomized controlled community based study was conducted to deter‐
mine whether or not H. pylori is a cause of IDA or a reason for treatment failure of iron supple‐
mentation in children with IDA [73]. The population consisted of 260 children, 2-5 years (200
H. pylori infected, detected by positive urea breath test [UBT], and 60 uninfected) with IDA. IDA
was defined as a combination of low hemoglobin (Hb <110 g/L) and a low serum ferritin (SF
<12 μg/L) plus elevated serum transferrin receptor (sTfR >8.3 mg/L) [74]. ID was defined as Hb
<110 g/L and SF <12 μg/L, or sTfR >8.3 mg/L. They were randomly assigned to one of 4 regimens:
(i)2-week course of anti-H. pylori (anti- H. pylori) triple therapy (amoxicillin 15mg/kg.dose and
clarithromycin 7.5mg/kg.dose, both administered twice daily; and a single 20 mg dose of
omeprazole per day) plus a 90-day course of oral ferrous sulfate in elixir (3 mg/kg elemental
iron daily) (anti- H. pylori therapy plus iron);(ii) a 2-week’s anti- H. pylori therapy plus place‐
bo for iron for 90 days (anti- H. pylori alone);(iii) 2-week’s course of placebo for anti- H. pylori
therapy but ferrous sulfate (3 mg/kg for 90 days) (Fe alone); and (iv) 2-week’s placebos for anti-
H. pylori therapy and a 90-day course of placebo for iron (positive control). For precisely
determining the role of H. pylori infection in the treatment failure of iron supplementation, the
study included a fifth group of children with IDA but without H. pylori infection (negative
control), who were treated with open iron therapy alone for 90 days. Iron status was reas‐
sessed after 90 days in all children; those with continued IDA/ID were given a 60-day course of
ferrous sulfate.
The results of the study indicated that iron status, as reevaluated on day-90, improved in all
groups. However, the improvement was significantly higher among 3 groups receiving iron
(anti- H. pylori plus iron, iron alone or negative control receiving iron). A greater proportion
of infected children receiving iron experienced correction of IDA than those receiving placebo
or anti- H. pylori alone (68% for anti- H. pylori plus iron, 76%)for iron alone, 25% for placebo
and 36% for anti- H. pylori alone, F=49, p <0.0001 (Figure 1). The results suggest no role of anti-
H. pylori in IDA. Regarding ID, iron therapy had the most pronounced effect - correction
occurred in 100% of children receiving iron compared to only 50% of children receiving anti-
H. pylori alone or placebo. It is important to note that compared to placebo or iron therapy,
anti- H. pylori therapy did not improve iron status or decrease IDA and ID prevalence.
Therefore, the study concluded that H. pylori is neither causally linked with IDA nor is a reason
for treatment failure of iron supplementation in children. The findings were in contrast with
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a randomized controlled trial by Choe and colleague who showed that treatment of the
infection was associated with a more rapid response to oral iron compared with iron supple‐
mentation alone, and that H. pylori eradication led to enhanced iron metabolism even in those
not receiving oral iron therapy, suggesting a causal relationship between H. pylori infection
and IDA [62]. A recent meta-analysis of 12 case reports and series, 19 observational epidemio‐
logic studies and 6 interventional trials, concluded H. pylori infection to be a major risk factor
for iron deficiency or IDA especially in high-risk groups [75]. Several other meta-analyses of
randomized controlled clinical trials suggested that treatment of H. pylori infection could be
effective in improving anemia and iron statue in IDA patients infected by H. pylori, particularly
in patients with moderate or severe anemia [76], [77], [78]. Although an association between
the pathogenesis of IDA and H. pylori infection has been well recognized, a causal link is yet
to be established.
Figure 1. Treatment failure (%) of anemia, IDA, and ID in children receiving different therapies. *Value of zero for the
Fe-alone group (Adapted from Sarker et. al. 2008)
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5.3. H. pylori and iron absorption
Non-heme iron absorption requires an acidic milieu. Non-water-soluble iron compounds, e.g.
ferrous and ferric pyrophosphate are often used in the fortification programs because they
cause no unacceptable organoleptic changes in the fortified food. However, these compounds
need gastric acid for their solubilization and absorption. Therefore, if gastric acid output is
compromised as a consequence of H. pylori infection in a large proportion of the target
population, the effect of food fortification programs using ferrous fumarate might be less than
expected due to reduced absorption of iron from fortified foods. Keeping this in mind, a study
was conducted in 12 Bangladeshi children to measure iron absorption from a non-water-
soluble iron compound (ferrous fumarate) and from a water-soluble iron compound (ferrous
sulfate) before and after treatment of their H. pylori infections. For comparison, 12 uninfected
age matched children were studied in parallel; all children had IDA [79]. Iron absorption from
ferrous fumarate was compared with that from a highly bioavailable, water-soluble iron
compound (ferrous sulfate) in a randomized, crossover study using a double stable-isotope
technique. Incorporation of 57Fe and 58Fe into erythrocytes 14 days after administration was
used as an index of iron absorption [80]. The study noted geometric mean of iron absorption
from ferrous sulfate and ferrous fumarate to be 19.7% and 5.3% respectively (P < 0.0001; n =
12) before treatment and 22.5% and 6.4% respectively after treatment (P < 0.0001; n = 11) of H.
pylori-infected children (Table 2). The corresponding values for uninfected children were 15.6%
and 5.4% (P < 0.001; n = 12). Geometric mean relative absorption (absorption of ferrous fumarate
compared to ferrous sulfate) was 26.9% and 34.8% in H. pylori-infected and uninfected children
respectively, and 28.3% in H. pylori-infected children after treatment. The results clearly
indicate that iron absorption from ferrous fumarate was significantly lower than that from
ferrous sulfate in both H. pylori-infected and uninfected Bangladeshi children and also that H.
pylori infection, per se, does not influence iron absorption in young children. The efficacy of
ferrous fumarate in iron fortification programs to prevent iron deficiency in young children
should, therefore, be further evaluated. The results of iron absorption tests may rule out the
possibility of H. pylori induced hypochlorhydria in interfering iron absorption in Bangladeshi
children.
5.3.1. Mechanism of IDA
The interaction between H. pylori and iron metabolism, based on clinical, ferrokinetic and
microbiological evidences has generated increasing interest. Iron is an essential micronutrient
for virtually all organisms, and H. pylorus is no exception. H. pylori may cause iron deficiency
anemia by competing with the host for the acquisition of alimentary iron. In the stomach,
ingested food provides iron in heme and nonheme forms. The low pH and the digestive
enzymes in the stomach release iron from ligands to the gastric lumen. H. pylori and the host
both compete for the free iron by deploying mechanisms specifically devised to sequester and
facilitate the acquisition of iron as well as other essential metals. H. pylori seems particularly
adept at competing for iron [81]; it has been established that H. pylori competes for iron in
murine hosts to an extent so as to cause iron deficiency when the dietary iron intake is poor
[82]. In order to ensure a sufficient supply of iron from the environment, H. pylori cells display
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a repertoire of high-affinity iron-uptake systems. It seems that H. pylori strains isolated from
patients with IDA demonstrates enhanced iron-uptake activity and may be more adept at
competing with the host for iron [83]. So far, little is known about how H. pylori cells acquire
iron bound to host-binding proteins. In-vitro studies indicate that human lactoferrin (LF)
supports full growth of H. pylori in media lacking other iron sources [72]. LF is released from
neutrophil, which captures iron from transferrin in conditions with iron-poor state (hypofer‐
rimia) and has been observed to be abundant in human stomach resection specimens from
patients with superficial or atrophic gastritis [84], [84]. The iron uptake by H. pylori via a specific
human LF receptor may thus play a major role in the virulence of H. pylori infection in its
uptake of iron. A 70-kDa LF-binding protein from the outer membrane proteins of H. pylori
was identified in bacterium grown in an iron-starved medium, implicating the protein in iron
uptake [85]. Comparative binding experiments with bovine or human LF, and with transferrin
of horse, bovine or human origin indicated that this protein is highly specific for human LF.
By means of this LF-binding protein, H. pylori is able to by-pass the human hypoferremic
defensive response -a phenomenon when total extracellular iron is reduced in the host limiting
bacterial growth. Further in vivo studies demonstrated increased concentration of LF in the
biopsy specimen [86] and in the gastric juice [86] of patients with H. pylori-related gastritis,
and also that LF tissue levels correlate significantly with the degree of inflammation of the
gastric mucosa. Two outer membrane proteins, FrpB1 and FrpB2 have also been implicated in
hemoglobin binding [81]. In keeping with this, the ability of H. pylori to use hemoglobin as an
H. pylori -infected children
before treatment (n=12)
H. pylori -infected children after
treatment (n=11) Uninfected children (n=12)
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% % %
Geometric
mean 5.3 19.7 26.9 6.4 22.5 28.3 5.4 15.6 34.8
+1SD 13.5 32.9 49.0 12.9 33.0 47.7 12.7 30.1 64.3
-1SD 2.1 11.8 14.8 3.2 15.4 16.8 2.3 8.1 18.8
P1 <0.0001 <0.0001 <0.001
1P value for iron absorption from ferrous fumarate compared with that from ferrous sulfate within each group.
Adapted from Sarker et al. 2004
Table 2. Fractional iron absorption from ferrous fumarate and ferrous sulfate in uninfected children with iron
deficiency anemia (IDA) and in Helicobacter pylori infected children with IDA before and after treatment
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iron source is well documented [87]. Several iron-repressible outer membrane proteins from
H. pylori, including FrpB1, seem to be responsible for heme utilization [88]
5.4. H. pylori and vitamin C
Ascorbic acid is the reduced form of the vitamin, which can act as a potent antioxidant for
neutralizing nitrite-derived mutagens protecting against gastric carcinogenesis [90]. Vitamin
C is first absorbed and then is actively secreted, mainly in the antral mucosa, from plasma into
gastric juice. Once there, it is able to react with nitrosating agents preventing N-nitroso
compounds formation; however, vitamin C in the stomach interacts with iron improving its
absorption. In children, H. pylori infection was associated with reduced gastric juice ascorbic
acid concentration, and the effect was more pronounced in patients with the CagA positive
strain [20]. In adults, H. pylori infection is also recognized to lower the concentration of vitamin
C in gastric juice as evident from a study involving randomly chosen 25-74 years old men and
women of north Glasgow, UK. Compared to the non-infected, the H. pylori infected had 20%
lower concentration of vitamin C in their plasma. [91]. The mechanism whereby H. pylori
infection lowers vitamin C concentration in gastric juice is unclear, but there are several
possibilities. Infection has been associated with significant reduction of gastric juice vitamin
C concentration due to chronic gastritis and/or H pylori oxidase activity [92]. Study in Korean
children also demonstrated significant negative correlation between vitamin C level in gastric
juice and the degree of active and chronic inflammation in the antral mucosa. Vitamin C levels
in whole blood, plasma, and gastric juice and the gastric juice pH were also closely related to
the severity of H. pylori infection and the histologic changes in the stomach in those children
[93].H. pylori has been noted to potentiate the polymorphonuclear leukocyte oxidative burst
[94], accompanied by a considerable production of reactive oxygen metabolites. Within the
microcirculation of the gastric mucosa ascorbic acid may be consumed during scavenging of
these reactive oxygen metabolites as vitamin C is the first line of defense against the oxygen
free radical damage in the human body [95]. Low level of Vitamin C may be a consequence of
an irreversible inactivation of the ingested vitamin C in the intestinal lumen prior to its
absorption. Studies have demonstrated that H. pylori produces reductions in stomach vitamin
C due to its degradation to dehydroascorbic acid (DHAA) - a metabolite that may be oxidized
afterwards irreversibly to 2,3- Diketo- 1-gluconic acid. DHAA is unstable at high pH values,
and thus hypochlorhydria or achlorhydria may reduce the stability even further and thus the
bioavailability of this vitamin.
In developing countries, low intake of vitamin C-enriched food is associated with higher
prevalence of H. pylori infection, and together will lead to significantly reduced systemic
availability of this vitamin. Therefore, prolonged H. pylori infection, as it is frequent in
developing countries, may impact absorption of several micronutrients including vitamin C.
The impact of H. pylori infection on the prevalence of micronutrient malnutrition is not
currently known, but it is known that there is a strong correlation of both high prevalence of
H. pylori infection and micronutrient deficiency in developing regions. Various fortification
programs are being carried out in developing regions using iron and/or zinc sources e.g.
electrolytic iron, ferric pyrophosphate, and zinc oxide. They need secretion of an adequate
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amount of hydrochloric acid for optimal absorption. Higher prevalence of H. pylori infection
is associated with low levels of vitamin C in serum and in gastric juice in children [20]; however,
there is no consensus about the usefulness of vitamin C supplementation in the management
of H. pylori infection. In review of the current literature, it may be concluded that high
concentration of vitamin C in gastric juice might inactivate H. pylori urease [98], the key enzyme
for survival of the pathogen and its colonization into acidic stomach. However, it is not certain
if vitamin C will be useful in regions with high prevalence of iron and/or zinc deficiency as
well as high H. pylori contamination rates.
6. Conclusion
The combination of micronutrient deficiency and more frequent enteric infections consequent
to H pylori–induced hypochlorhydria is likely to have a profound impact on health of children
in developing countries with high prevalence of H pylori and lower intake of reliable nutritional
sources of bioavailable iron and ascorbic acid. Thus, prevention of H pylori infection could
potentially have an important impact on iron deficiency anemia or other micronutrient
deficiencies in the developing world.
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